Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

971
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
971
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

244
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
244
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

70
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
70
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

32
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
32
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

771
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
771
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

2.0K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trach and treat: Safety and motor outcomes following onasemnogene abeparvovec in patients with spinal muscular atrophy and tracheostomies in the RESTORE registry.

Journal of neuromuscular diseases·2025
Same author

Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE Registry.

Journal of neuromuscular diseases·2024
Same author

Combination disease-modifying treatment in spinal muscular atrophy: A proposed classification.

Annals of clinical and translational neurology·2023
Same author

Identifying Potentially Preventable Reasons Nurses Intend to Leave a Job.

The Journal of nursing administration·2022
Same author

The Psychometric Analysis of the Certified Registered Nurse Anesthetist Workload Perception Scale (CWPS): Final Phase.

Journal of nursing measurement·2021
Same author

Optimizing factor VIII dosing in obese individuals with haemophilia A.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2021
Same journal

Neuropsychologists' Engagement With and Cognitive Assessment in Parkinson's Disease: A Mixed Methods Australian Investigation.

Journal of geriatric psychiatry and neurology·2026
Same journal

Attention Networks Connectivity After Cognitive Rehabilitation in Alzheimer's Disease.

Journal of geriatric psychiatry and neurology·2026
Same journal

Associations Between Immigration-Related Factors and Cognition Among Hispanics, the HABS-HD Study.

Journal of geriatric psychiatry and neurology·2026
Same journal

Mild Behavioural Impairment and Everyday Functioning in Cognitively Unimpaired Older Adults: Evidence From the CAN-PROTECT Study.

Journal of geriatric psychiatry and neurology·2026
Same journal

Distinguishing Agitation From Aggression in Neurocognitive Disorders: A Systematic Review of Conceptualization, Assessment and Correlates.

Journal of geriatric psychiatry and neurology·2026
Same journal

The Myth of Tithonus: Ageing and Dementia in Ancient Greek Thought.

Journal of geriatric psychiatry and neurology·2026
See all related articles

Related Experiment Video

Updated: Oct 21, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

Statins, Enzyme CoQ10 Supplement Use, and Cognitive Functioning.

Brian G Collin1, Dheeraj Raju2, Steven Katsikas1

  • 1Spalding University School of Professional Psychology, Louisville, KY, USA.

Journal of Geriatric Psychiatry and Neurology
|September 8, 2021
PubMed
Summary
This summary is machine-generated.

This study found no significant cognitive benefits from statin or Coenzyme Q10 (CoQ10) supplements in the Wisconsin Alzheimer

Keywords:
Alzheimer’s diseaseCoQ10auditory memorycognitive flexibilitydementiapsychomotor speedstatin

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.7K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.2K

Related Experiment Videos

Last Updated: Oct 21, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.7K
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.2K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Gerontology

Background:

  • Cognitive decline is a major concern in aging populations.
  • Statins and Coenzyme Q10 (CoQ10) are commonly used supplements with potential neuroprotective effects.
  • Understanding their impact on cognition is crucial for preventative strategies.

Purpose of the Study:

  • To investigate the association between statin and CoQ10 supplement use and cognitive function changes.
  • To analyze cognitive performance in participants of the Wisconsin Registry for Alzheimer's Prevention (WRAP) study.

Main Methods:

  • 1,573 participants underwent regular cognitive assessments over 5-10 years.
  • Cognitive tests included MMSE, RAVLT, Wechsler Memory Scale, and Trail Making Test (TMT A & B).
  • Linear mixed models were employed to analyze the effects of statin and CoQ10 use.

Main Results:

  • No significant effects of statin or CoQ10 supplement use were observed on cognitive changes.
  • Specific cognitive domains assessed included mental status, learning, memory, psychomotor speed, and cognitive flexibility.
  • Statistical analysis did not reveal a link between supplement use and performance on neuropsychological tests.

Conclusions:

  • Statin and CoQ10 supplement use showed no association with cognitive function in the WRAP study cohort.
  • These findings suggest that statins and CoQ10 may not influence cognitive trajectories in this population.
  • Further research may be needed to explore other factors influencing cognitive health in aging.